180 related articles for article (PubMed ID: 28447161)
1. Prediction of graft-versus-host disease: a biomarker panel based on lymphocytes and cytokines.
Budde H; Papert S; Maas JH; Reichardt HM; Wulf G; Hasenkamp J; Riggert J; Legler TJ
Ann Hematol; 2017 Jul; 96(7):1127-1133. PubMed ID: 28447161
[TBL] [Abstract][Full Text] [Related]
2. γδ T Cells May Aggravate Acute Graft-Versus-Host Disease Through CXCR4 Signaling After Allogeneic Hematopoietic Transplantation.
Wu N; Liu R; Liang S; Gao H; Xu LP; Zhang XH; Liu J; Huang XJ
Front Immunol; 2021; 12():687961. PubMed ID: 34335589
[TBL] [Abstract][Full Text] [Related]
3. Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease.
Gebremedhin E; Behrendt CE; Nakamura R; Parker P; Salehian B
Inflammation; 2013 Feb; 36(1):177-85. PubMed ID: 22987342
[TBL] [Abstract][Full Text] [Related]
4. The clinical value of anal swabs for microbial detection in allogeneic haematopoietic stem cell transplantation.
Gao J; Lin D; Hou C; Shen Y; Li Y; Wu D; Xu Y
Transplant Cell Ther; 2023 Oct; 29(10):619.e1-619.e9. PubMed ID: 37499872
[TBL] [Abstract][Full Text] [Related]
5. Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.
Merli P; Caruana I; De Vito R; Strocchio L; Weber G; Del Bufalo F; Buatois V; Montanari P; Cefalo MG; Pitisci A; Algeri M; Galaverna F; Quintarelli C; Cirillo V; Pagliara D; Ferlin W; Ballabio M; De Min C; Locatelli F
Haematologica; 2019 Nov; 104(11):2314-2323. PubMed ID: 30792213
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review.
Bhattarai A; Shah S; Yadav R; Dhakal G; Neupane R; Paudel S; Bhandari P; Abu Serhan H; Sah R; Sah S; Barboza JJ
Hematology; 2024 Dec; 29(1):2293497. PubMed ID: 38112182
[TBL] [Abstract][Full Text] [Related]
7. Disturbance in the reconstitution of distinct T-cell subsets and the incidence of GvHD following allo-HSCT in pediatric patients with non-malignant hematological disorders.
Bayegi SN; Hamidieh AA; Behfar M; Bozorgmehr M; Saghazadeh A; Tajik N; Delbandi AA; Zavareh FT; Delavari S; Shekarabi M; Rezaei N
Immunol Lett; 2023 Sep; 261():25-36. PubMed ID: 37474024
[TBL] [Abstract][Full Text] [Related]
8. Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse.
Iamsawat S; Tian L; Daenthanasanmak A; Wu Y; Nguyen HD; Bastian D; Yu XZ
Blood Adv; 2019 Dec; 3(24):4187-4201. PubMed ID: 31856270
[TBL] [Abstract][Full Text] [Related]
9. GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.
Hess NJ; Brown ME; Capitini CM
Front Immunol; 2021; 12():723544. PubMed ID: 34394131
[TBL] [Abstract][Full Text] [Related]
10. A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.
Qayed M; Kapoor U; Gillespie S; Westbrook A; Aguayo-Hiraldo P; Ayuk FA; Aziz M; Baez J; Choe H; DeFilipp Z; Etra A; Grupp SA; Hexner E; Holler E; Hogan WJ; Kowalyk S; Merli P; Morales G; Nakamura R; Pulsipher MA; Schechter T; Shah J; Spyrou N; Srinagesh HK; Wölfl M; Yanik G; Young R; Kitko CL; Ferrara JLM; Levine JE
Transplant Cell Ther; 2024 Jun; 30(6):603.e1-603.e11. PubMed ID: 38548227
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profiles during engraftment syndrome and acute graft-versus-host disease in adult patients after hematopoietic stem cell transplantation.
Wu B; Jiang C; Jin L; Azadan X; Lin J; Lin L; Nie X; Cai G
Cytokine; 2024 Jun; 178():156582. PubMed ID: 38493534
[TBL] [Abstract][Full Text] [Related]
12. Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation.
Cheng AP; Cheng MP; Loy CJ; Lenz JS; Chen K; Smalling S; Burnham P; Timblin KM; Orejas JL; Silverman E; Polak P; Marty FM; Ritz J; De Vlaminck I
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058359
[No Abstract] [Full Text] [Related]
13. [Clinical study of the cytokine panel in the diagnosis of ocular chronic graft-versus-host disease].
Cheng XJ; Ji R; Huan RH; Huang SQ; Fan W; Zhao YC; Yuan RD; Wang XQ; Zhang X
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):242-248. PubMed ID: 38716595
[No Abstract] [Full Text] [Related]
14. Ocular surface characterization after allogeneic stem cell transplantation: A prospective study in a referral center.
Alba-Linero C; Rodriguez Calvo de Mora M; Lavado Valenzuela R; Pascual Cascón MJ; Martín Cerezo AR; Álvarez Pérez M; Recio LV; Jerez Aragonés JM; García Campos JM
Indian J Ophthalmol; 2020 Aug; 68(8):1556-1562. PubMed ID: 32709775
[TBL] [Abstract][Full Text] [Related]
15. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants.
Iacobescu M; Pop C; Uifălean A; Mogoşan C; Cenariu D; Zdrenghea M; Tănase A; Bergthorsson JT; Greiff V; Cenariu M; Iuga CA; Tomuleasa C; Tătaru D
Front Immunol; 2024; 15():1327035. PubMed ID: 38433830
[TBL] [Abstract][Full Text] [Related]
16. Anti-ICOS mAb Targets Pathogenic IL-17A-expressing Cells in Canine Model of Chronic GVHD.
Parker MH; Stone D; Abrams K; Johnson M; Granot N; Storb R
Transplantation; 2021 May; 105(5):1008-1016. PubMed ID: 33065723
[TBL] [Abstract][Full Text] [Related]
17. In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets.
Beilhack A; Schulz S; Baker J; Beilhack GF; Wieland CB; Herman EI; Baker EM; Cao YA; Contag CH; Negrin RS
Blood; 2005 Aug; 106(3):1113-22. PubMed ID: 15855275
[TBL] [Abstract][Full Text] [Related]
18. A novel soluble form of Tim-3 associated with severe graft-versus-host disease.
Hansen JA; Hanash SM; Tabellini L; Baik C; Lawler RL; Grogan BM; Storer B; Chin A; Johnson M; Wong CH; Zhang Q; Martin PJ; McDonald GB
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1323-30. PubMed ID: 23791624
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges.
Hefazi M; Bolivar-Wagers S; Blazar BR
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575843
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory CD4/CD8 double-positive human T cells arise from reactive CD8 T cells and are sufficient to mediate GVHD pathology.
Hess NJ; Turicek DP; Riendeau J; McIlwain SJ; Contreras Guzman E; Nadiminti K; Hudson A; Callander NS; Skala MC; Gumperz JE; Hematti P; Capitini CM
Sci Adv; 2023 Mar; 9(12):eadf0567. PubMed ID: 36961891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
